摘要
本研究旨在探索胃二方加减治疗胃癌前病变(GPL)的临床疗效。选用90例GPL病例,治疗组30例,以胃二方加减治疗;对照组Ⅰ30例,用胃复春治疗;对照组Ⅱ30例,用胶体次枸橼酸铋治疗。结果:治疗组临床症状总有效率为96.67％,较对照组Ⅰ的60.00％有显著性差异(P<0.05)。胃镜病理疗效3组无统计学差异(P>0.05),但其中对异型增生(DYS)的疗效治疗组明显优于两对照组。
For observation on clinical therapeutic effect of modified Wei Er Fang on gastric precanceraus lesion (GPL), 90 cases of GPL were divided into 3 groups, the treatment group treated with modified Wei Er Fang, the control group I treated with Wei Fu Chuan and the control group I with Bismuth subcitrate, 30 cases each group. Results indicated that the total effective rate for clinical symptoms was 96. 67% in the treatment group which was significant different from 60. 00% in the control group I (P < 0. 05). There was no significant difference among the 3 groups in pathological therapeutic effect of gastroscopy (P > 0. 05), but the therapeutic effect on heterotypic proliferation in the treatment group was superior to those in the two control groups. It is showed that modified Wei Er Fang has a better action of reversing gastric precancerous lesion.
出处
《中医杂志》
CSCD
北大核心
2002年第4期275-276,共2页
Journal of Traditional Chinese Medicine
关键词
胃二方
胃癌前病变
胃肿瘤
中医药疗法
癌前状态
Gastric tumor/TCM therapy, precancerous state, / TCM therapy, @Wei Er Fang
